SCHEMBL23928486

SCHEMBL23928486

COC(=O)c1ccc(/C(C)=N/Nc2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.61
MAPT P10636 10/20 0.61
SMN1; SMN2 Q16637 8/20 0.61
NPC1 O15118 8/20 0.61
ALDH1A1 P00352 6/20 0.61
HPGD P15428 4/20 0.61
TSHR P16473 1/20 0.56
GAA P10253 5/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
L3MBTL1 Q9Y468 3/20 0.54
CASP3 P42574 1/20 0.54
SENP8 Q96LD8 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
SENP6 Q9GZR1 1/20 0.54
POLB P06746 3/20 0.54
KDM4E B2RXH2 1/20 0.51
TDP1 Q9NUW8 2/20 0.50
CASP6 P55212 1/20 0.50
CA1 P00915 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12670647 0.95 TSHR (0.59) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL4413307 0.82 GAA (0.69) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL13345208 0.82 GAA (0.69) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL3273659 0.82 GAA (0.69) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL23392549 0.82 GAA (0.58) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL28874995 0.81 GAA (0.59) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL23928652 0.81 FAAH (0.54) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL12670648 0.80 RAB9A (0.68) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL19652417 0.80 RAB9A (0.68) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL11684865 0.80 ALDH1A1 (0.59) RAB9AMAPTSMN1; SMN2NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548875-B2 Inhibitor compounds for male contraception UNIVERSITY OF WASHINGTON (US) 2023-01-10 US disclosed
US-20210332030-A1 INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION UNIVERSITY OF WASHINGTON (US) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332030-A1 INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION ALDH1A1, ALDH3A1, ALDH16A1 RAB9A 4266/4885MAPT 4083/4885SMN1; SMN2 2873/4885
US-11548875-B2 Inhibitor compounds for male contraception ALDH1A1, ALDH3A1, ALDH16A1 RAB9A 4266/4885MAPT 4083/4885SMN1; SMN2 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.